世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031840

血漿プロテアーゼC1阻害薬の世界市場(2022-2026)

TechNavio

Global Plasma Protease C1 Inhibitor Market 2022-2026

発刊日 2022/03/29

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000031840

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、血漿プロテアーゼC1阻害薬市場を分析します。

世界の血漿プロテアーゼC1阻害薬市場は、予測期間中に約7.4 %のCAGRで推移し、2022年から2026年の間に17億USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。研究開発の活発化、製品の承認・上市の増加、無機的な戦略の採用が市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 凍結乾燥
      ◇ 注射剤
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、ブラジキニンB2受容体拮抗薬の増加傾向を、今後数年間の血漿プロテアーゼC1阻害薬市場の成長を促す主要な理由の1つとして挙げています。また、政府の積極的な取り組みと高品質の医療ソリューションの導入が、市場の大きな需要につながると考えられます。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 血漿プロテアーゼC1阻害薬の市場規模
  • 血漿プロテアーゼC1阻害薬の市場予測
  • 血漿プロテアーゼC1阻害薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な血漿プロテアーゼC1阻害薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Alexion Pharmaceuticals Inc.
    ➣ argenx SE
    ➣ Bausch Health Companies Inc.
    ➣ BIOCRYST PHARMACEUTICALS Inc.
    ➣ bluebird bio Inc.
    ➣ Bristol Myers Squibb Co.
    ➣ CSL Ltd.
    ➣ FibroGen Inc.
    ➣ Fresenius Kabi AG
    ➣ Gilead Sciences Inc.
    ➣ GlaxoSmithKline Plc
    ➣ Bio Inc.
    ➣ Ionis Pharmaceuticals Inc.
    ➣ KalVista Pharmaceuticals Inc.
    ➣ Novartis AG
    ➣ Pharming Group NV
    ➣ Sanquin
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Vertex Pharmaceuticals Inc.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Lyophilized - Market size and forecast 2021-2026
Exhibit 28: Chart on Lyophilized - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Lyophilized - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Lyophilized - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Lyophilized - Year-over-year growth 2021-2026 (%)
5.4 Injectable - Market size and forecast 2021-2026
Exhibit 32: Chart on Injectable - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Injectable - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Injectable - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Injectable - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 BIOCRYST PHARMACEUTICALS Inc.
Exhibit 85: BIOCRYST PHARMACEUTICALS Inc. - Overview
Exhibit 86: BIOCRYST PHARMACEUTICALS Inc. - Product / Service
Exhibit 87: BIOCRYST PHARMACEUTICALS Inc. - Key offerings
10.4 CSL Ltd.
Exhibit 88: CSL Ltd. - Overview
Exhibit 89: CSL Ltd. - Business segments
Exhibit 90: CSL Ltd. - Key news
Exhibit 91: CSL Ltd. - Key offerings
Exhibit 92: CSL Ltd. - Segment focus
10.5 Fresenius Kabi AG
Exhibit 93: Fresenius Kabi AG - Overview
Exhibit 94: Fresenius Kabi AG - Business segments
Exhibit 95: Fresenius Kabi AG - Key news
Exhibit 96: Fresenius Kabi AG - Key offerings
Exhibit 97: Fresenius Kabi AG - Segment focus
10.6 GlaxoSmithKline Plc
Exhibit 98: GlaxoSmithKline Plc - Overview
Exhibit 99: GlaxoSmithKline Plc - Business segments
Exhibit 100: GlaxoSmithKline Plc - Key news
Exhibit 101: GlaxoSmithKline Plc - Key offerings
Exhibit 102: GlaxoSmithKline Plc - Segment focus
10.7 Ionis Pharmaceuticals Inc.
Exhibit 103: Ionis Pharmaceuticals Inc. - Overview
Exhibit 104: Ionis Pharmaceuticals Inc. - Business segments
Exhibit 105: Ionis Pharmaceuticals Inc. - Key news
Exhibit 106: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 107: Ionis Pharmaceuticals Inc. - Segment focus
10.8 KalVista Pharmaceuticals Inc.
Exhibit 108: KalVista Pharmaceuticals Inc. - Overview
Exhibit 109: KalVista Pharmaceuticals Inc. - Product / Service
Exhibit 110: KalVista Pharmaceuticals Inc. - Key offerings
10.9 Novartis AG
Exhibit 111: Novartis AG - Overview
Exhibit 112: Novartis AG - Business segments
Exhibit 113: Novartis AG - Key offerings
Exhibit 114: Novartis AG - Segment focus
10.10 Pharming Group NV
Exhibit 115: Pharming Group NV - Overview
Exhibit 116: Pharming Group NV - Business segments
Exhibit 117: Pharming Group NV - Key offerings
Exhibit 118: Pharming Group NV - Segment focus
10.11 Takeda Pharmaceutical Co. Ltd.
Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key offerings
10.12 Vertex Pharmaceuticals Inc.
Exhibit 123: Vertex Pharmaceuticals Inc. - Overview
Exhibit 124: Vertex Pharmaceuticals Inc. - Product / Service
Exhibit 125: Vertex Pharmaceuticals Inc. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 126: Inclusions checklist
Exhibit 127: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 128: Currency conversion rates for US$
11.4 Research methodology
Exhibit 129: Research methodology
Exhibit 130: Validation techniques employed for market sizing
Exhibit 131: Information sources
11.5 List of abbreviations
Exhibit 132: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Lyophilized - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Lyophilized - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Lyophilized - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Lyophilized - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Injectable - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Injectable - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Injectable - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Injectable - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: BIOCRYST PHARMACEUTICALS Inc. - Overview
Exhibits86: BIOCRYST PHARMACEUTICALS Inc. - Product / Service
Exhibits87: BIOCRYST PHARMACEUTICALS Inc. - Key offerings
Exhibits88: CSL Ltd. - Overview
Exhibits89: CSL Ltd. - Business segments
Exhibits90: CSL Ltd. - Key news
Exhibits91: CSL Ltd. - Key offerings
Exhibits92: CSL Ltd. - Segment focus
Exhibits93: Fresenius Kabi AG - Overview
Exhibits94: Fresenius Kabi AG - Business segments
Exhibits95: Fresenius Kabi AG - Key news
Exhibits96: Fresenius Kabi AG - Key offerings
Exhibits97: Fresenius Kabi AG - Segment focus
Exhibits98: GlaxoSmithKline Plc - Overview
Exhibits99: GlaxoSmithKline Plc - Business segments
Exhibits100: GlaxoSmithKline Plc - Key news
Exhibits101: GlaxoSmithKline Plc - Key offerings
Exhibits102: GlaxoSmithKline Plc - Segment focus
Exhibits103: Ionis Pharmaceuticals Inc. - Overview
Exhibits104: Ionis Pharmaceuticals Inc. - Business segments
Exhibits105: Ionis Pharmaceuticals Inc. - Key news
Exhibits106: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits107: Ionis Pharmaceuticals Inc. - Segment focus
Exhibits108: KalVista Pharmaceuticals Inc. - Overview
Exhibits109: KalVista Pharmaceuticals Inc. - Product / Service
Exhibits110: KalVista Pharmaceuticals Inc. - Key offerings
Exhibits111: Novartis AG - Overview
Exhibits112: Novartis AG - Business segments
Exhibits113: Novartis AG - Key offerings
Exhibits114: Novartis AG - Segment focus
Exhibits115: Pharming Group NV - Overview
Exhibits116: Pharming Group NV - Business segments
Exhibits117: Pharming Group NV - Key offerings
Exhibits118: Pharming Group NV - Segment focus
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits123: Vertex Pharmaceuticals Inc. - Overview
Exhibits124: Vertex Pharmaceuticals Inc. - Product / Service
Exhibits125: Vertex Pharmaceuticals Inc. - Key offerings
Exhibits126: Inclusions checklist
Exhibits127: Exclusions checklist
Exhibits128: Currency conversion rates for US$
Exhibits129: Research methodology
Exhibits130: Validation techniques employed for market sizing
Exhibits131: Information sources
Exhibits132: List of abbreviations

この商品のレポートナンバー

0000031840

TOP